Victory Capital Management
LFCR icon

Victory Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Victory Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,294
Closed -$37K – 2915
2020
Q1 		$37K Buy
+4,294
New +$44.7K ﹤0.01% 2612
2019
Q4 		– Sell
-4,939
Closed -$54K – 2972
2019
Q3 		$54K Buy
+4,939
New +$53.8K ﹤0.01% 2648

Other funds holding LFCR

Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return

Victory Capital Management's LFCR Position: Q2 2020 in Review

Victory Capital Management sold out of Lifecore Biomedical (LFCR) in Q2 2020, closing a stake of 4,294 shares — an estimated $37K sold.

Victory Capital Management first reported a position in LFCR in Q3 2019 and held it in 2 quarters. The position peaked at $54K in Q3 2019. 95 funds tracked by Wall St. Rank hold LFCR as of Q2 2020.

  • Victory Capital Management reported no remaining Lifecore Biomedical position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 4,294 Lifecore Biomedical shares in Q2 2020, an estimated $37K.
  • Victory Capital Management first reported a position in Lifecore Biomedical in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Lifecore Biomedical position peaked at $54K in Q3 2019.
  • 95 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.